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ABSTRACT
Macroautophagy/autophagy delivers damaged proteins and organelles to lysosomes for degradation,
and plays important roles in maintaining tissue homeostasis by reducing tissue damage. The transloca-
tion of LC3 to the limiting membrane of the phagophore, the precursor to the autophagosome, during
autophagy provides a binding site for autophagy cargoes, and facilitates fusion with lysosomes. An
autophagy-related pathway called LC3-associated phagocytosis (LAP) targets LC3 to phagosome and
endosome membranes during uptake of bacterial and fungal pathogens, and targets LC3 to swollen
endosomes containing particulate material or apoptotic cells. We have investigated the roles played by
autophagy and LAP in vivo by exploiting the observation that the WD domain of ATG16L1 is required for
LAP, but not autophagy. Mice lacking the linker and WD domains, activate autophagy, but are deficient
in LAP. The LAP−/- mice survive postnatal starvation, grow at the same rate as littermate controls, and are
fertile. The liver, kidney, brain and muscle of these mice maintain levels of autophagy cargoes such as
LC3 and SQSTM1/p62 similar to littermate controls, and prevent accumulation of SQSTM1 inclusions and
tissue damage associated with loss of autophagy. The results suggest that autophagy maintains tissue
homeostasis in mice independently of LC3-associated phagocytosis. Further deletion of glutamate E230
in the coiled-coil domain required for WIPI2 binding produced mice with defective autophagy that
survived neonatal starvation. Analysis of brain lysates suggested that interactions between WIPI2 and
ATG16L1 were less critical for autophagy in the brain, which may allow a low level of autophagy to
overcome neonatal lethality.
Abbreviations: CCD: coiled-coil domain; CYBB/NOX2: cytochrome b-245: beta polypeptide; GPT/ALT:
glutamic pyruvic transaminase: soluble; LAP: LC3-associated phagocytosis; LC3: microtubule-associated
protein 1 light chain 3; MEF: mouse embryonic fibroblast; NOD: nucleotide-binding oligomerization
domain; NADPH: nicotinamide adenine dinucleotide phosphate; RUBCN/Rubicon: RUN domain and
cysteine-rich domain containing Beclin 1-interacting protein; SLE: systemic lupus erythematosus;
SQSTM1/p62: sequestosome 1; TLR: toll-like receptor; TMEM: transmembrane protein; TRIM: tripartite
motif-containing protein; UVRAG: UV radiation resistance associated gene; WD: tryptophan-aspartic acid;
WIPI: WD 40 repeat domain: phosphoinositide interacting
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Introduction
Autophagy generates autophagosomes that deliver cyto-
plasmic material to lysosomes for degradation.
Macroautophagy, hereafter referred to as autophagy, is
activated during starvation and provides a short-term
supply of amino acids to sustain protein synthesis and
energy production. At the same time, basal autophagy
helps to prevent tissue damage during development and
ageing by reducing the accumulation of damaged proteins
and organelles [1,2]. Autophagosome formation involves
the recruitment of LC3 from the cytosol to the limiting
membrane of the phagophore where it provides a binding
site for autophagy cargoes, and facilitates fusion with
lysosomes. Recent studies [3] show that LC3 is also
recruited to membranes by an autophagy-related pathway
called LC3-associated phagocytosis (LAP). LAP is acti-
vated by TLR signalling and NADPH oxidase during pha-
gocytosis of fungal and bacterial pathogens, and results in
attachment of LC3 to the cytosolic side of the phagosome
membrane where it facilitates phagosome maturation [4].
A similar LAP-like noncanonical autophagy pathway also
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operates in nonphagocytic cells resulting in recruitment of
LC3 to single-membraned endolysosomal compartments
during entosis, micropinocytosis [5] and following lysoso-
motropic drug treatment [6,7], and may occur during the
uptake of particulate material or apoptotic cells [8–11].
Autophagy and LAP provide 2 different pathways for
removing unwanted material from cells, but the relative
roles played by each pathway in reducing tissue damage and
maintaining homeostasis in vivo are not clear. Autophagy-null
mice die shortly after birth because they are unable to adapt to
the starvation that follows loss of placental nutrition [12].
Mice with tissue-specific loss of autophagy survive, but the
tissues lacking autophagy invariably accumulate ubiquitin-
positive inclusions containing protein aggregates and show
signs of inflammation and tissue damage. These studies have
inactivated autophagy genes such as Atg3, Atg5, Atg7, Atg12
and Atg16L1 [12–16] that are essential for both autophagy
and LAP, making it impossible to determine if tissue damage
results from loss of autophagy, or LAP, or both. Studies on
LAP in vivo have focused on inactivation of RUBCN/Rubicon
in myeloid cells [3,4]. rubcn−/- myeloid cells are LAP-deficient
and show defects in clearance of bacterial and fungal patho-
gens and dying and apoptotic cells. These mice also have
elevated levels of inflammatory cytokines, and eventually
develop an autoimmune disease that resembles systemic
lupus erythematosus (SLE) [4,17]. While suggestive of a role
for LAP in preventing inflammation and autoimmunity, the
targeted loss of RUBCN from myeloid cells does not inform
on the role played by LAP in non-myeloid cell types in vivo.
The recruitment of LC3 to membranes during both autop-
hagy and LAP requires the E3 ligase-like activity of the
ATG12–ATG5-ATG16L1 complex, which covalently binds
LC3 to membranes. ATG16L1 contains an N-terminal
domain that binds the ATG12–ATG5 conjugate (Figure 1),
followed by a coiled-coil domain (CCD) that binds WIPI2
[18]. WIPI2 brings the ATG12–ATG5-ATG16L1 complex to
phagophore membranes allowing conjugation of LC3 to
phosphatidylethanolamine [19]. In higher eukaryotes, a linker
region attaches the CCD to a large C-terminal WD (trypto-
phan-aspartic acid) domain containing 7 WD repeats folded
into a circular β-propeller [20,21]. Recent studies show that
the WD domain of ATG16L1 is required for LAP [22]. This
allowed us to generate LAP-deficient mice by inserting 2 stop
codons in frame at the end of the CCD of the Atg16L1 gene
(Figure 1). This mutation, called atg16l1E230, allowed transla-
tion of the glutamate E226 and E230 residues in the CCD
required for WIPI2 binding and autophagy [18], but pre-
vented translation of the linker region and WD domain
required for LAP. In a second mouse, called atg16l1E226, an
unexpected recombination removed the E230 glutamate resi-
due required for WIPI2 binding. This mouse survived post-
natal starvation but was defective in autophagy and LAP in all
tissues. We have used these 2 mouse strains to determine the
roles played by autophagy and LAP in reducing tissue damage
and maintaining tissue homeostasis in vivo.
Results
Mice lacking the WD and linker domain of ATG16L1 were
generated by homologous recombination in embryonic stem
cells. The targeting vector was designed to insert 2 stop
codons after glutamate residue E230 in the CCD, followed
by the bovine growth hormone polyadenylation site and a frt-
flanked neomycin cassette. Homologous recombination was
verified by Southern blotting. RNA analysis of the F1 genera-
tion established from independent chimeras showed that most
mice carried the correct sequence and expressed the E230
residue required for autophagy. Surprisingly, some mice had
a 14 base pair (bp) deletion at the end of the CCD, which
deleted glutamate E230 and its preceding amino acid, fol-
lowed by a stop codon (Figure 1 A and B). These mouse
strains were termed atg16l1E230 and atg16l1E226.
Figure 1. Generation of mice lacking the WD and linker domains of ATG16L1. (A) Domain structure of ATG16L1. The N-terminal ATG5 binding domain (ATG5 b) binds
the ATG12–ATG5 conjugate. The coiled-coil domain (CCD) binds WIPI2 through glutamates E226 and E230. A linker domain separates the CCD from the 7 WD repeats
of the WD domain. (B) Sites of stop codons. atg16l1E230; 2 stop codons were inserted into exon 6 immediately after glutamate E230 to preserve binding sites for
WIPI2, but prevent translation of the linker and WD domain. atg16l1E226; an unexpected recombination inserted a glycine residue at position 228. (C) Tissue lysates
were separated by SDS-PAGE and transferred to nitrocellulose membranes. Separate membranes sections were analyzed by western blot using antibody specific for
ATG16L1.
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Expression of the truncated ATG16L1E230 CCD was ver-
ified by comparing western blots of tissue lysates from the
atg16l1E230 mice with littermate controls (Figure 1C). The
ATG5 binding and CCD of ATG16L1 migrated at ~ 27 kDa
compared to the ~ 70 kDa for full-length ATG16L1. As
described by Mizushima et al [21], lysates from liver showed
the α and β isoforms of ATG16L1 while the slower migrating
β isoform predominated in muscle and brain. Full-length
ATG16L1 was present in lysates obtained from littermate
controls, but absent from tissues of atg16l1E230 mice. It was
not possible to detect the truncated CCD of the atg16l1E226
mice, in whole tissue lysates. This may be because the epitope
is lost, or the protein is highly unstable.
The size of the ATG16L1 complex generated in the mice was
determined by gel filtration of cytoplasmic fractions isolated
from homogenized liver (Figure 2). In control mice the α and
β isoforms of ATG16L1 eluted in high molecular-mass fractions
suggesting formation of a 300–600 kDa complex. Previous work
has shown that elution of ATG16L1 in high molecular-weight
fractions is dependent on ATG5 [21]. The presence of the
ATG12–ATG5 conjugate in the same high molecular weight
fractions as ATG16L1 suggested binding of ATG5 to the
N-terminal ATG5-binding domain present in the CCD of
ATG16L1. Full-length ATG16L1 contains the E226 and E230
glutamate residues required for WIPI2 binding, and indirect
evidence for binding to WIPI2 was provided by the elution of
Figure 2. Analysis of ATG16L1 complexes in liver by gel filtration. The cytosolic fraction of liver homogenates was separated by size-exclusion chromatography on an
ENrichTMSEC 650 column. Fraction (0.5 ml) were analyzed by immunoblot for ATG16L1, ATG5 and WIPI2 as indicated. Void volume 10 ml. Migration and elution of
molecular mass standards are shown (kDa).
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the 49-kDa WIPI2 protein in high molecular-mass factions ran-
ging between 150 and 600 kDa. Analysis of the atg16l1E230 and
atg16l1E226 mice was complex because the preparation of liver
lysates appeared to result in limited proteolysis of CCDs, and the
possible formation of dimers and trimers resistant to dissocia-
tion during SDS polyacrylamide electrophoresis (Fig. S1). The
blots in Figure 2 show the elution profile of the 27-kDa CCD and
the 25-kDa proteolytic products, which co-elute with multimers
at 50 and 75 kDa (Fig. S1). The bulk of the CCD in the liver of
atg16l1E230 mice eluted over a broad range from 50–400 kDa in
fractions which also contained the ATG12–ATG5 conjugate and
ATG5. As seen for control mice, WIPI2 was detected in high
molecular-mass fractions eluting between 400–600 kDa; how-
ever, levels of WIPI2 were less than seen for control, and a low
molecular-mass fraction was also detected between 50 and 100
kDa. The CCD of atg16l1E230 mice retained binding sites for
ATG5 and WIPI2, and the elution profiles were consistent with
assembly of complexes containing the CCD, ATG12–ATG5 and
WIPI2. Unlike whole tissue lysates, it was possible to detect the
CCD of the atg16l1E226 mouse in fractions eluting from the gel
filtration column. The CCD eluted over a broad 30–400 kDa
range in fractions that also contained ATG12–ATG5. The CCD
of atg16l1E226mice lacks the E230 glutamate residue required for
WIPI2. The blots show that unlike control mice and atg16l1E230
mice, it was not possible to detectWIPI2 in highmolecular-mass
fractions, andWIPI2 eluted between 50 and 100 kDa. The results
from this indirect assay based on the size of ATG16L1 complexes
suggest that the CCD of atg16l1E226 assembles with ATG12–
ATG5 through the ATG5 binding domain, but does not bind
strongly to WIPI2.
The ability of cells isolated from the mice to activate
autophagy was tested by western blot of autophagy substrates
SQSTM1/p62 (sequestosome 1) and LC3, and by following
formation of LC3 puncta after starvation in Hanks balanced
salt solution (HBSS) (Figure 3A-C). Mouse embryonic fibro-
blasts (MEFs) from mice lacking ATG16L1 (atg16l1−/-) were
used as an autophagy-negative control. MEFs from control
mice expressed the α and β isoforms of ATG16L1 which were
absent from atg16l1−/-, atg16l1E226 and atg16l1E230MEFs,
whereas atg16l1E230 MEFs showed the smaller band expected
at 27 kDa (data not shown). atg16l1−/- MEFs showed defects
in autophagy indicated by the expression of high levels of the
autophagy substrate SQSTM1, and an inability to generate
lipidated LC3-II (Figure 3A) after starvation. MEFs expressing
ATG16L1E226 also expressed high levels of SQSTM1 and were
unable to generate lipidated LC3-II showing that loss of E230
resulted in defects in autophagy. This supported the observa-
tion that MEFs (Figure 3B) and skin fibroblasts (Figure 3C)
from atg16l1E226 mice were unable to generate LC3 puncta
following starvation. In contrast, cells expressing full-length
ATG16L1, or expressing the CCD but lacking the WD
domain (ATG16L1E230) were able to activate autophagy, indi-
cated by low basal levels of SQSTM1 and generation of LC3
puncta in response to HBSS (Figure 3B,C). Taken together,
these results showed that autophagy requires the E226 and
E230 glutamate residues in the CCD needed for WIPI2 bind-
ing, but, as reported previously [19], autophagy did not
require the WD domain. The role played by the WD domain
during LAP was analyzed by incubating bone marrow-derived
macrophages (BMDMs) from the mouse strains with
Pam3CSK4 (a mimic of bacterial lipopeptides)-coupled poly-
styrene beads to follow LC3 translocation to phagosomes
(Figure 3D). LC3 was recruited to phagosomes in macro-
phages from control mice, but not in macrophages from
autophagy-defective atg16l1E226 mice, or atg16l1E230 mice
that lack the WD domain and linker region of ATG16L1. As
reported previously [22,23] these observations indicate that
the WD domain is required for LAP in myeloid cells, and
Figure 3. Role played by WD and linker domains of ATG16L1 during autophagy and LC3-associated phagocytosis. (A) MEFs from mice lacking ATG16L (FL KO),
atg16l1E226 (E226) and atg16l1E230 (E230) and appropriate littermate controls were incubated in complete media or HBSS for 2 h to induce autophagy. Cell lysates
were analyzed by western blot using antibodies specific for the indicated proteins. (B) MEFs or skin fibroblasts (C) from atg16l1E226 (E226) and atg16l1E230 (E230) mice
and littermate controls were incubated in complete media or HBSS for 2 h to induce autophagy. Cells were immunostained for endogenous LC3. (D) BMDMs from
atg16l1E226 (E226) and atg16l1E230 (E230) and appropriate littermate controls were incubated with Pam3CSK4-coupled polystyrene beads for 1.5 h in complete
medium to induce LAP, and immunostained for endogenous LC3 (green). Boxed regions highlighting internalized beads are enlarged and shown in the lower panel.
Magnification 63X, scale bars: 10 µm.
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confirmed that the atg16l1E230 mouse would provide a LAP-
deficient mouse model to study the role played by LAP in
maintaining tissue homeostasis in vivo.
Mouse growth and survival
The LAP-deficient atg16l1E230 mice survived the postnatal leth-
ality seen in atg16l1−/- mice [15], and were similar in size and
weight to littermate controls and grew at comparable rates
(Figure 4A, B). atg16l1E230 mice were born with Mendelian
frequency with reproductive organs of normal size, and were
fertile with a reproductive capacity comparable to controls (data
not shown). The survival rate and litter sizes of atg16l1E230 mice
were similar to wild-type mice with life spans of at least
24 months (data not shown). The majority of atg16l1E226 mice
also survived postnatal lethality, but most grew slowly
(Figure 4A, B) and died within 5–7 months of age.
Inflammatory cytokines
LAP-deficient mice generated by Lyz2/LysM-cre-driven loss of
Rubcn frommacrophages, monocytes and neutrophils (3) develop
a SLE-like syndrome characterized by an age-dependent increase
in serum cytokines and eventual generation of antibodies against
nuclear antigens. Serum levels of IL1B, IL12 (p70), IL13, TNF, IL6
and CCL2/MCP1 reported to be elevated in rubcn−/- mice were
measured in control, atg16l1E230 and atg16l1E226 mice. Serum
levels of IL1B, IL12 (p70), IL13, and TNF/TNF-α in atg16l1E230
and atg16l1E230 mice were the same as littermate controls at 8–12
and 20–24 wk. Elevated levels of IL6 and CCL2/MCP1 were
detected in the autophagy-defective atg16l1E226 mice, but these
were not seen in control or atg16l1E230 mice (Fig. S2). It was not
possible to detect antinuclear antibodies able to stain the nuclei of
cells in culture. The LAP−/- atg16l1E230 mice do not therefore
appear to develop the pro-inflammatory phenotype seen for
rubcn−/- mice lacking LAP in phagocytic cells.
Liver
A preliminary survey of the internal organs of the mouse strains
showed that defects were most obvious in the liver of the
autophagy-defective atg16l1E226 mice. The livers (Figure 5A)
showed pronounced hepatomegaly with average liver weights of
2.6 g, compared to 1.6 g of control mice, and when liver weight
was expressed as percentage of body weight (Figure 5B) to com-
pensate for the smaller size of the atg16l1E226 mouse, livers were
more than twice the size (11%) of littermate controls (5%). These
results are in line with studies of mice with targeted loss of Atg7 in
liver [13], or the hepatomegaly observed in atg5−/- mice where
Atg5 is restored in neuronal tissue [24]. Liver damage was evident
from elevated levels of serum GPT/ALT (glutamic pyruvic trans-
aminase, soluble), a liver function marker enzyme (Figure 5C). In
contrast, there was little evidence for hepatomegaly in atg16l1E230
LAP-deficient mice with mean weights of 1.8 g being the compar-
able to littermate controls, and these mice did not show the raised
serum GPT/ALT levels seen in autophagy-defective mice.
Autophagy function in liver tissue was assessed by western blot
of SQSTM1 and LC3, which are substrates for autophagy and are
degraded in lysosomes. The signals for full-length ATG16L1 were
present in blots of 3 representative livers taken from control mice.
Two bands were seen, consistent with the expression of α and β
isoforms of ATG16L1 in liver [21], but absent from blots of
atg16l1E226 and atg16l1E230 mice (Figure 5D). Liver lysates from
the atg16l1E226mouse showed raised levels of LC3-I and SQSTM1
compared to control mice, suggesting impaired clearance of
autophagy substrates ‘in vivo’ (Figure 5D). Immunohistological
analysis showed SQSTM1 inclusions in hepatocytes, indicative of
accumulation of damaged proteins and organelles in atg16l1E226
mice (Figure 5E). In contrast livers from the LAP-deficient
atg16l1E230 mice were similar in size to littermate controls
(Figure 5A), and lysates did not reveal raised levels of LC3-I and
SQSTM1 (Figure 5D).Moreover, SQSTM1 inclusions were absent
from hepatocytes (Figure 5E), suggesting that autophagy is active
in the liver. Further analysis confirmed that hepatomegaly in
atg16l1E226 mice correlated with hepatocellular hypertrophy as
evidenced by the enlarged circumference of hepatocytes
(Figure 6A) and increased hepatocyte proliferation indicated by
a 4-fold increase in MKI67/Ki67 immunostaining (Figure 6B).
Liver inflammation was also evident from increased infiltration of
ITGAM/CD11b-positive leukocytes (Figure 6C). In contrast,
livers from the atg16l1E230 mice showed little sign of damage. A
comparison of the mice suggested that LAP was not required to
Figure 4. Phenotype of atg16l1E226 and atg16l1E230 mice. (A) Representative pictures of mice at ~2 months of age (scale bar: 1 cm). (B) Body weight of mice and
littermate controls fed on chow diet. Mice were weighed at the indicted times and each point is generated from at least 6 individuals (n = 11 and 6 for E230
(atg16l1E230) and control, respectively; n = 11 and 8 for E226 (atg16l1E226) and control, respectively. Statistical analysis was done by unpaired t test. Error bars
represents ±SEM. ****-P < 0.0001.
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Figure 5. Analysis of autophagy substrates in liver. Panel (A) Representative livers at ~2 months (scale bar: 1 cm). (B) Liver weight expressed as a percentage of body
weight at 2–3 months of age. E230 (atg16l1E230) n = 9, control n = 8; E226 (atg16l1E226) n = 9, control n = 7. (C) GPT/ALT in serum from mice aged between
2–3 months. E230 (atg16l1E230) n = 7, control n = 5; E226 (atg16l1E226) n = 5, v control n = 5. (D) Western blot of liver lysates from 3 representative mice. Membranes
strips taken from the appropriate molecular weight range were analyzed separately using the indicted antibodies. (E) Representative histochemical sections of livers
immunostained for SQSTM1. Enlarged regions of interest are shown in the lower panel. Arrows: SQSTM1 inclusions. In all figures data from littermate controls for
E230 and E226 were pooled. Statistical analysis was done by unpaired t test. Error bars represents ±SEM. ****-P < 0.0001, ***-P < 0.001; ns, non-significant. Image
magnification 40X, scale bars: 50 µm.
Figure 6. Analysis of liver homeostasis. (A) Representative images of H&E-stained sections of livers. Boxed regions of interest are enlarged in lower panels. The bar
graph represents comparative circumferences of hepatocytes (n = 10) across the indicated strains (n = 3 for all the strains). (B and C) Representative histochemical
sections of liver immunostained with antibodies against MKI67/Ki67 (B) or ITGAM/Cd11b (C). Regions of interest are enlarged and shown in lower panels. Arrows
indicate positive staining. Bar graphs show number of positive cells (C) or percent positive cells (B). Five different zones for each liver section were analyzed (n = 3 for
all the strains). Data across littermate control mice for E230 and E226 were pooled. Statistical analysis was done by unpaired t test. Error bars represents ±SEM.
****-P < 0.0001, *-P < 0.1. Magnification 20X, scale bars: 50 µm.
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suppress tissue damage because the liver parenchyma damage,
hepatocellular hypertrophy (Figure 6A) and raised serum GPT/
ALT levels (Figure 5C) seen in the atg16l1E226 mice, were absent
from atg16l1E230 mice. Furthermore, hepatocyte proliferation
(Figure 6B) was comparable to that found in littermate controls.
There was evidence of low level inflammatory cell infiltration in
the livers from atg16l1E230 mice (Figure 6C), possibly indicating a
role for LAP in reducing inflammation, but levels of ITGAM/
Cd11b-positive cells were much lower than seen in livers of
autophagy-defective atg16l1E226 mice.
Muscle and kidney
The atg16l1E226 mice showed evidence of muscle wasting
because the gastrocnemius muscle was significantly smaller
in atg16l1E226 mice when muscle weight was expressed as a
percentage of body weight (Figure 7A). Lysates from muscle
had high levels of SQSTM1 and LC3 (Figure 7B), and when
normalized for GAPDH expression, muscle lysates from the
atg16l1E226 mice showed 2–3 fold increases in LC3-I, and
nearly 6-fold increases in SQSTM1 compared to control
mice (Figure 7C), suggesting impaired clearance of autophagy
substrates ‘in vivo’. This was consistent with histological sec-
tions of muscle showing multiple SQSTM1 inclusions
(Figure 7D). Morphological analysis of muscle did not, how-
ever, reveal the degenerative changes observed in mice lacking
ATG7 in muscle tissue [25], such as vacuolated and centrally
nucleated myofibers.
The kidneys of atg16l1E226 mice weighed less than con-
trols, but this difference was not statistically significant
when expressed as a percentage of body weight
(Figure 8A). Kidney lysates of atg16l1E226 mice contained
raised levels of LC3-I and SQSTM1 (Figure 8B and C) and
histological sections of kidney showed multiple SQSTM1
inclusions (Figure 8D). We were not, however, able to
find evidence of obvious kidney damage and glomerular
architecture remained intact. In contrast to the autophagy-
negative atg16l1E226 mice, the muscle and kidney of
LAP−deficient atg16l1E230 mice were of comparable size to
littermate controls (Figures 7A and 8A) and blots of tissue
lysates did not show raised levels of LC3-I or SQSTM1
(Figures 7B and 8B), consistent with the absence of
SQSTM1 inclusions in tissue sections (Figures 7D and
8D). As seen for liver, tissue homeostasis in kidney and
muscle required autophagy, but did not require the WD
domain of ATG16L1 and was, therefore maintained inde-
pendently of LAP.
Brain
The autophagy-defective atg16l1E226 mice showed a range of
neurological defects including loss of motor coordination,
abnormal limb clasping and an unusual splayed gait suggest-
ing defects in both the peripheral and central nervous system
(data not shown). The neurological phenotype of autophagy-
defective atg16l1E226 mice mirrored the loss of motor coor-
dination seen in mice deficient in ATG7 in the central
nervous system [26]. The brains of the atg16l1E226 mice
were smaller than littermate controls, but there was no
significant difference when brain weights were expressed as
a percentage of body weight (Figure 9A). There were high
levels of SQSTM1 in brain lysates (Figure 9B and C), and
brain sections showed evidence of SQSTM1 inclusions
(Figure 9D). In contrast, brain lysates from the LAP-defi-
cient atg16l1E230 mice had levels of LC3-I and SQSTM1
similar to controls (Figure 9B and C), and brains lacked
SQSTM1 inclusions (Figure 9D). Although motor coordina-
tion appeared normal in the majority of the atg16l1E230 mice,
some developed head tilt suggesting defects in the inner ear
or possible ear infection.
Figure 7. Analysis of muscle. (A) Gastrocnemius muscle weight expressed as a percentage of body weights at 2–3 months of age. E230 (atg16l1E230) n = 6, control
n = 5; E226 (atg16l1E226) n = 8, control n = 6. (B) Western blot of muscle lysates from 3 representative mice. Membrane strips taken from the appropriate molecular
weight range were analyzed separately by western blot using the indicted antibodies. (C) Bar graphs show levels of LC3 and SQSTM1 relative to GAPDH. (D)
Histochemical sections of muscle were immunostained with antibodies against SQSTM1. Enlarged regions of interest are shown in the lower panels. Arrows: SQSTM1
inclusions. Statistical analysis was done by unpaired t test. Error bars represent ±SEM. ***-P < 0.001, **-P < 0.01; ns, non-significant. Magnification 20X, scale bar:
50 µm.
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Mice with systemic loss of ATG16L1 from all tissues (atg16l1−/-)
die at birth from a suckling defect [15]. This raised the question
of how the atg16l1E226 mice, which appear autophagy-defective,
survive neonatal lethality. Neonatal lethality in atg5−/- mice can
be reversed by brain-specific re-expression of ATG5 [24]. These
rescued mice (atg5-null) lack ATG5 and autophagy in non-neu-
ronal tissues and develop multiple organ abnormalities with a
phenotype closely resembling the atg16l1E226 mouse described
here. Both the atg5-null and atg16l1E226 mice, survived neonatal
lethality, but grew slowly compared to control mice, and have
pronounced hepatomegaly and sarcopenia. This makes it possi-
ble that atg16l1E226 mice described in our study survive neonatal
lethality because they carry out a low level of autophagy in the
brain. Interestingly, the LC3-I levels in the brain of atg16l1E226
mice were the same as controls (Figures 9B and 9C). This was in
contrast to peripheral tissues such as liver (Figure 5D), muscle
(Figure 7B and C) and kidney (Figure 8B and C) where LC3 was
elevated 3-4 fold. The preservation of control levels of LC3-I in
atg16l1E226 mice suggest that LC3 may be degraded in the brain
by autophagy. This observation, and the striking similarity in
phenotype with the neuronal-specific rescue of atg5-null mice
described by Yoshii et al [24], suggests that the brain of atg16l1-
E226 mice may compensate for the loss of autophagy arising from
loss of the E230 residue required for WIPI2 binding. The size
exclusion analysis of liver extracts in Figure 2 showed the elution
of WIPI2 in high molecular-weight fractions in mice expressing
full-length ATG16L1 or the CCD of ATG16L1 that retained
glutamate E230 required for WIPI2 binding, but not in mice
expressing the ATG16L1E226 CCD lacking E230. This provides
an indirect assay for binding of WIPI2 to ATG16L1 when gel
Figure 8. Analysis of kidney. (A) Kidney weights at 2–3 months expressed (i) directly: E230 (atg16l1E230 n = 8, control n = 8, E226 (atg16l1E226) n = 7, control = 8; or as
(ii) percentage body weight: E230 (atg16l1E230 n = 9, control n = 8, E226 (atg16l1E226) n = 7, control = 6. (B) Western blot of kidney lysates from 3 representative mice.
Membranes strips taken from the appropriate molecular weight range were analyzed separately using the indicted antibodies. (C) Bar graphs show levels of LC3 and
SQSTM1 relative to GAPDH. (D) Histochemical sections of kidneys immunostained for SQSTM1. (G) Indicates glomerulus. Enlarged regions of interest are shown in
lower panels. Arrows: SQSTM1 inclusions. Data from control mice were pooled. Statistical analysis was done by unpaired t test. Error bars represent ±SEM.
***-P < 0.001, **-P < 0.01; ns, non-significant. Magnification 20X, scale bars: 50 µm.
Figure 9. Analysis of brain. (A) Brain weights at 2–3 months expressed (i) directly: E230 (atg161E230 n = 8, control n = 7, E226 (atg16l1E226) n = 7, control = 7; or (ii) as
percentage body weight: E230 (atg161E230 n = 8, control n = 9, E226 (atg16l1E226) n = 6, control = 5. (B) Western blot of brain lysates from 3 representative mice.
Membrane strips taken from the appropriate molecular weight range were analyzed separately by western blot using the indicted antibodies. (C) Bar graphs show
levels of LC3 and SQSTM1 relative to GAPDH. (D) Histochemical sections of brains were immunostained for SQSTM1. Enlarged regions of interest are shown in lower
panels. Arrows indicate SQSTM1 inclusions. Data from control mice were pooled. Statistical analysis was done by unpaired t test. Error bars represents ±SEM.
***-P < 0.001, *-P < 0.1; ns, non-significant. Magnification 20X, scale bars: 50 µm.
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filtration was repeated for brain lysates (Figure 10). As seen in
liver, ATG16L1 in control mice eluted in high molecular-mass
fractions suggesting formation of a 300- to 600-kDa complex.
These same fractions contained the ATG12–ATG5 conjugate,
but surprisingly these fractions did not contain WIPI2, which
eluted between 50 and 100 kDa (Figure 10). Similarly, the
ATG16L1E230 and ATG16L1E226 CCDs formed high molecular-
weight complexes and co-eluted with ATG12–ATG5 but were
unable to move WIPI2 to high molecular-weight fractions. The
profiles resembled that seen for the ATG16L1E226 CCD in liver
that lacks the E230 glutamate required for WIPI2 binding
(Figure 2). Taken together the results suggested that the binding
of ATG16L1 to WIPI2 differs in brain compared to liver. This
may provide the basis for a low level of autophagy in brain that
allows the atg16l1E226 mice to survive neonatal lethality.
Discussion
We have generated mice lacking the WD and linker domains
of ATG16L1 to study the roles played by autophagy and LAP
in maintaining tissue homeostasis in vivo. The atg16l1E230
mice were unable to activate LAP, but retained glutamate
E226 and E230 in the CCD required for WIPI2 binding and
could therefore activate autophagy. These mice grew at the
same rate as littermate controls, were fertile and did not have
obvious defects in liver, kidney, brain or muscle homeostasis.
This suggests that autophagy rather than LAP plays a major
role in reducing tissue damage in vivo. The WD domain of
ATG16L1 in higher eukaryotes including insects, nematodes,
Figure 10. Analysis of ATG16L1 complexes in brain by gel filtration. The cytosolic fraction of brain homogenates was separated by size-exclusion chromatography on
an ENrichTMSEC 650 column. Fraction (0.5 ml) were analyzed by immunoblot for ATG16L1, ATG5 and WIPI2 as indicated. Void volume 10 ml. Migration and elution of
molecular mass standards are shown (kDa).
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plants and humans contains over half the amino acids of the
66-kDa protein [21]. Gel filtration analysis suggested that full-
length ATG16L1 formed a 300- to 600-kDa complex in liver
and brain. The CCDs of the atg16l1E230 and atg16l1E226 mice
eluted over a broad size ranging from 50–400 kDa suggesting
multimeric assembly in the absence of the WD domain. These
results are consistent with previous gel filtration analysis [21]
demonstrating 600- to 800-kDa complexes of ATG16L1 in
lysates of liver, brain and fibroblast cell lines, and the forma-
tion of additional smaller complexes ranging between 100 and
300 kDa in fibroblasts expressing ATG16L1 lacking the WD
domain. Initial calculations based on gel filtration suggest
formation of complexes containing 8 copies of ATG16L1
bound to the ATG12–ATG5 conjugate [21]. Later work ana-
lyzing the ATG16L1 complex by sucrose gradient sedimenta-
tion suggests ATG16L1 exists as a dimer [27]. This
discrepancy in size estimation could be explained if
ATG16L1 adopted an elongated conformation in solution
accelerating its elution from gel filtration columns.
Regardless of the precise size of complexes formed by
ATG16L1 and the CCDs of the atg16l1E230 and atg16l1E226
mice, all three co-eluted with ATG12–ATG5. This increase in
apparent size of the 72 kDa ATG12–ATG5 conjugate suggests
the conjugate binds all 3 CCDs via the N-terminal ATG5
binding domain. The binding of WIPI2 to ATG16L1 requires
glutamate E230 in the CCD, which is absent in the CCD of
the atg16l1E226 mice. The lack of elution of WIPI2 in high
molecular-weight liver fractions containing the CCD of the
atg16l1E226 mouse suggested that loss of glutamate E230
results in reduced WIPI2 binding in vivo.
The WD domains of ATG16L1 represent as much as a
third of the total protein. It is perhaps remarkable that this
complex of 7 bladed β-propellers, which are thought to pro-
vide a platform for protein-protein interactions important for
autophagy, play little role in maintaining tissue homeostasis
‘in vivo’. Instead, evolution appears to have confined this
important role to the N-terminal ATG5 binding and CC
domains conserved through to the yeast ortholog Atg16
[28]. Binding of ATG16L1 to WIPI2 requires glutamate resi-
dues E226 and E230 in the ATG16L1 CCD, which bind
arginine R108 and R125 exposed on the surface of WIPI2.
Deletion of either E226 or E230 in ATG16L1 abrogates bind-
ing to WIPI2, and expression of WIPI2 lacking R108 and
R125 is unable to reconstitute LC3 recruitment to phago-
phores in WIPI2-depleted cells [18]. Our study shows that
the integrity of this WIP2 binding site within the short
N-terminal domain is critical for autophagy in vivo, because
loss of one amino acid, E230, required for WIPI2 binding,
results in loss of autophagy and results in multiple tissue
abnormalities.
Macrophages and fibroblasts cultured from mice lacking
the WD domain were unable to activate LAP. This is in
agreement with previous work [22], showing that the WD
domain is required for several noncanonical pathways that
recruit LC3-II to endocytic compartments. These include
newly formed macropinosomes, phagosomes containing
latex beads or apoptotic corpses, endosomes swollen by mon-
ensin or a combination of ammonium chloride and the
vacuolating toxin A from Helicobacter pylori, and endosomes
targeted by the M2 proton channel encoded by influenza
virus. Furthermore, loss of the WD domain from ATG16L1
in dendritic cells results in reduced secretion of TNF and IL1B
in response to CLEC4N/Dectin2 signalling [23] and reduced
antigen presentation by dendritic cells [22]. The requirement
of the WD domain for LAP suggests that the scaffold pro-
vided by the WD domains of ATG16L1 has evolved a specia-
lized role, independent of autophagy, to ensure the quality
control of endocytic pathways by conjugating LC3 to phago-
somes containing pathogens or apoptotic cells, or endocytic
compartments showing signs of damage. This is supported by
the observation that the WD domain of ATG16L1 binds
NOD-like receptors [29], MEFV/TRIM20 [30], TMEM59
[31] and EVA1A/TMEM166 [32], which are important in
pathogen recognition. Our observation that mice remain
viable and maintain tissue homeostasis over long periods in
the absence of the WD domain suggests that LAP does not
play an essential role in preventing tissue damage in vivo. LAP
in phagocytic cells requires RUBCN and CYBB/NOX2 [3] and
mice with Lyz2/LysM-cre-targeted disruption of either of these
genes in macrophages, monocytes and neutrophils, grow
slowly. We did not observe slowed growth for the atg16l1E230
LAP-defective mice suggesting that loss of LAP from all
tissues allows mice to compensate for loss of LAP in phago-
cytic cells. Alternatively, the deletion of the WD domain, and
loss of RUBCN and CYBB/NOX2, inactivate LAP by different
mechanisms. ATG16L1 is downstream of RUBCN and CYBB/
NOX2, and it will be interesting to determine if the WD
domain interacts with RUBCN or UVRAG or components
of the CYBB/NOX2 complex. Defective clearance of apoptotic
cells following LAP deficiency resulting from lack of CYBB/
NOX2 or RUBCN in phagocytic cells predisposes mice to an
autoimmune disease resembling systemic lupus erythemato-
sus [4]. At 52 wk, rubcn−/- mice have increased levels of
antibody against double-stranded DNA, anti-nuclear antibo-
dies and deposition of immune complexes in the kidney. Our
analysis of LAP-deficient atg16l1E230 mice at 20–24 wk did not
show elevated cytokines or anti-nuclear antibodies (not
shown), but this does not preclude development of lupus-
like autoimmunity as they age further.
MEFs cultured from atg16l1E226 mice were unable to activate
autophagy in response to starvation, and the mice showed accu-
mulation of SQSTM1 in vivo. These mice grew slowly, were
infertile and showed defects in liver, brain and muscle home-
ostasis, and neurological defects similar to those reported for
mice with analogous tissue-specific loss of autophagy genes.
These mice again highlight the importance of autophagy for
maintaining tissue health in vivo, but, surprisingly, the atg16l1E226
mice were able to survive neonatal lethality. These mice therefore
differ from mice with systemic deletion of Atg3, Atg5, Atg12 or
Atg16l1, which die within hours of birth because they cannot
compensate for loss of placental nutrition [12,14,15]. This suggests
that the truncated CCDE226 may provide functions that are miss-
ing when Atg16l1 is deleted completely. The CCDE226 retains the
ATG5 binding domain allowing the CCD E226 to bind the
ATG12–ATG5 conjugate and assemble into an ATG12–ATG5-
ATG16L1 CCDE226 complex. This complex may maintain E3
ligase activity and be able to facilitate lipidation of LC3 and
autophagosome formation at a low level. Evidence for a low
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level of autophagy is provided in Figure 3A where accumulation
of SQSTM1 in MEFs from atg16l1E226 appeared lower than fol-
lowing complete loss of ATG16L1, and there was a feint band for
LC3-II. In addition, the requirement for WIPI2 binding to
ATG16L1 to initiate autophagy may differ between brain and
peripheral tissues. Support for this is provided by gel filtration
analysis which suggested that binding of WIPI2 to the E230
glutamate residue in the CCD of ATG16L1 occurred in liver,
but binding was much weaker in brain.
The phenotype of the atg16l1E226 mouse was very similar
to the atg5-null mouse described by Yoshii et al [24] where
ATG5 expression was restored in the brain of atg5−/- mice.
In common with atg16l1E226 mice, the atg5-null mouse
survived neonatal lethality but grew slowly and showed
SQSTM1 accumulation in peripheral tissues, particularly
liver and muscle. The atg5-null mice were sterile and have
the pronounced hepatomegaly seen in atg16l1E226 mice.
This makes it possible that a low level of autophagy in the
brain of atg16l1E226 mice allows them to survive neonatal
lethality. Indirect evidence for this is provided by the obser-
vation that LC3-I levels were not raised in the brains of
atg16l1E226 mice (Figure 8B) compared to muscle
(Figure 6B), liver (Figure 4D) and kidney (7B). The trun-
cated CCDE226 is able to protect against neonatal lethality,
but not able to provide long-term protection against neu-
rological defects. This phenotype is similar to the mice
lacking ATG7 in the central nervous system [26] where
neurons accumulate SQSTM1 inclusions and ubiquitin,
and Purkinjie cells and pyramidal neurons are lost from
the cerebellar cortex.
Materials and methods
Construction of the targeting vector
A P1 artificial chromosome (PAC) mouse genomic DNA
library (Source BioScience, 711_RPCI21mPAC) was
screened with a 0.5-kb Xho I-Sal I fragment obtained from
the Atg16l1 IMAGE cDNA clone 6,813,377/AV130 A2
(Source BioScience). A 10-kb XhoI and a 13-kb BamHI
fragment, containing exons 1–10 of Atg16l1, were subcloned
into pBSIISK- (Agilent, 212,206). Two stop codons and
restriction sites for NheI, XhoI, EcoRV and EcoRI were
introduced into exon 6 after amino acid position 230 by
PCR. Two 1.5-kb fragments were generated using primer
pairs CCAAATCCAGGTACCTCTCAG.seq in combination
with ATCCTCGAGATCGATGCTAGCCTACTATTCCTTT
GCTGCTTCTGCAAG.rev and ATCGATCTCGAGGATA
TCGAATTCCCTCTACCTGTTGAACAGTG.seq in combi-
nation with CCTGGCCCGGGCATGATAATG.rev, followed
by an annealing PCR of the 2 fragments using primers
CCAAATCCAGGTACCTCTCAG.seq and CCTGGCCCG
GGCATGATAATG.rev to generate a 3-kb fragment, which
was cloned into a SmaI-cut pUC19 vector (Addgene,
50,005). The bovine growth hormone polyadenylation site
(bGH-pA; derived from pPGK-Cre-bpA, Addgene, 11,543)
was cloned into the blunt-ended XhoI site, followed by
cloning the blunt-ended PGK-Neo-frt cassette [33] into
EcoRV. A KpnI-SmaI fragment of an 8.7-kb SacI-SmaI
fragment, generated from the 10-kb XhoI and 13-kb
BamHI genomic clones, was then exchanged with the mod-
ified exon 6-containing genomic PCR fragment.
Embryonic stem cells and generation of homozygous
mice
Embryonic stem cells were cultured as described previously
[34]. R1 cells (2x107) [35] were electroporated with 30 µg
NotI-linearized targeting vector as described. G418-resistant
clones were screened by Southern hybridization for homolo-
gous recombination. Positive clones were expanded, re-ana-
lyzed by Southern blot analysis and PCR, and injected into
C57L/B6 blastocysts. Highly chimeric male founder mice were
obtained, which were crossed with C57LB/6 females to obtain
heterozygous F1 offspring. The neomycin cassette was
removed by crossing F1 offspring with FlpO transgenic mice
[36] and mice were subsequently crossed onto a C57L/B6
background. Genotype analysis was performed using primers
CAAATATGCCTTCAGAACTG and GCTGTAGTTCCAA
TCCCTAA, resulting in 290-bp and 640-bp fragments for
wild-type and mutant mice, respectively.
Mice
These studies used adult male and female mice of approxi-
mately 2–3 months of age from the first cross of 129 and
C57BL/6. All experiments were performed in accordance with
UK Home Office guidelines and under the UK Animals
(Scientific procedures) Act1986. The growth rate of these
mice was estimated by recording weights each week. Mice
were killed by schedule-1 procedures and dissected to harvest
brain, liver, gastrocnemius muscle and kidney. The weights of
the organs were recorded before fixing or freezing.
Cells and cell culture
MEFs were generated by serial passage of cells taken from
mice at embryonic day 13.5 and cultured in DMEM
(ThermoFisher scientific, 11,570,586) with 10% FCS.
BMDMs were generated from bone marrow isolated from
femur and tibia flushed with RPMI 1640 (Sigma, R8758).
Macrophages were generated by culturing adherent cells in
RPMI 1640 containing 10% FCS and CSF1/M-CSF
(Peprotech, 315–02; 30 ng/ml) for 6 d. Macrophage popula-
tions were quantified by FACS using antibodies against
FCGR3/CD16-FCGR2B/CD32, ADGRE1/F4/80 and ITGAM/
CD11b (BioLegend, 101,320, 123,107).
Autophagy and LC3-associated phagocytosis
Autophagy was activated by incubating cells in HBSS
(ThermoFisher, 11,550,456) to create starvation for 2 h at
37°C. LAP was stimulated in bone marrow-derived macro-
phages by Pam3CSK4-coupled beads. Carboxyl-modified
beads (polybead carboxylate 3.0 µm, 09850) were conjugated
with Pam3csk4 (invivogen, TLRL-PMS) by following the
manufacturer’s protocol (Bangs Laboratories, Inc. Tech Note
205, III.). Pam3CSK4-coupled beads were added to
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macrophage cultures at a ratio of 10:1 (bead/cell) for 1.5 h
before being fixed and the location of LC3 analyzed by immu-
nofluorescence microscopy.
Tissue western blotting
Dissected tissue was snap-frozen in liquid nitrogen, ground to
a fine powder under liquid nitrogen and lysed in RIPA buffer
(150 mM sodium chloride, 1% TritonX-100 [Sigma, P1379-
1L], 0.5% sodium deoxycholate [Sigma, D-5670], 0.1% sodium
dodecyl sulfate [Fisher Bioreagents, BP166-500], 50 mM Tris,
pH 8.0) containing protease (Sigma, P8340) and phosphatase
(Sigma, P5726) inhibitors followed by homogenization and
freeze thaw. Samples were clarified by centrifugation
(10,600 g, 10 min at 4°C). Supernatants containing ̴ 10 ug
protein were boiled in Laemmli buffer followed by SDS-
PAGE using 4–12% gradient gels (Expedeon, NBT41212).
The resolved proteins were electro-blotted onto nitrocellulose
membrane (Bio-Rad, 1,620,115), blocked (5% skimmed milk
in 1X TBS [50mM Tris (pH 7.5), 150mM NaCl], 1 h, room
temperature) and then probed first with appropriate primary
(ATG16L1 [MBL, M150-3], SQSTM1/p62 [Abcam, ab91526],
GAPDH [Abcam, ab9482] and LC3A/B [Cell Signalling
Technology, 4108]) and then secondary antibody (Cell
Signalling Technology, 7074S and 7076S). Blots were visua-
lized by exposure to Supersignal West Pico chemiluminescent
substrate (ThermoFisher Scientific, 34,080). Bands were quan-
tified through ImageJ (NIH, USA), analyzed (unpaired t-test)
and plotted via GraphPad prism 7 software.
Cell western blotting
Protein was extracted using M-PER (ThermoFisher Scientific,
78,501) with complete protease inhibitor cocktail (Sigma,
04693159001) for 30 min on ice. Samples were clarified by
centrifugation (10,600Xg, 10 min). From the supernatants, pro-
tein concentrations were determined using the BCA protein
assay system (ThermoFisher Scientific, 23,225) according to the
manufacturer’s protocol. Protein (20 µg) was separated on a
precast 4–12% gradient SDS-PAGE gel (Expedeon, NBT41212)
and transferred to immobilon PVDF (Millipore, IPFL00010) for
blotting. Membranes were probed using antibodies for
ATG16L1 (MBL), SQSTM1/p62, (Abcam), LC3A/B and
ACTB/actin (Sigma, A5441). Primary antibodies were detected
using IRDye labelled secondary antibodies (LI-COR biosciences,
926–32,211, 926–68,020) at 1∶10,000 dilution. Proteins were
visualized using the Odyssey infrared system (LI-COR).
Gel filtration chromatography
Freshly dissected livers and brains were suspended in cold
phosphate-buffered saline (Oxoid, BR0014G) containing
protease inhibitors (Roche, 05892791001) and homogenized
using a Dounce homogenizer. Particulate material was
removed by sequential centrifugation at 100Xg and
13,000Xg (4°C) for 20 min. The supernatants were clarified
by ultracentrifugation (100,000Xg, 4°C, 1 h) and analyzed
by the gel filtration using an ENrichTMSEC 650 (Bio-Rad,
780–1650,) column and AKTA purifier (GE Healthcare) to
collect 0.5-ml fractions. Fractions were analyzed by SDS-
PAGE followed by western blotting on PVDF membranes
probed for ATG16L1, ATG5 (Abcam, ab108327) and WIPI2
(Abcam, ab101985). The void volume (Vo) was estimated
using Blue dextran (Sigma, D4772-1VL) and the elution
volumes (Ve) of molecular size standards (Sigma,
MWGF1000) allowed the determination of Ve: V0 ratios to
create a standard curve.
Cytokine assays
Serum from young (2–3 months) and aged (5–6 months) mice
were analyzed for cytokines using ProcartaPlexTM Simplex
Immunoassay kits (ThemoFisher Scientific, EPX01A-26,015–
901, EPX01A-20,603–901, EPX01A-26,004–901, EPX01A-
26,005–901, EPX01A-20,607–901 and EPX01A-26,002–901) by
following the manufacturer’s instructions. Samples were read on
a Luminex TM 100/200TM instrument (Luminex Corp.).
Histochemistry
Dissected tissues were fixed in 10% neutral buffer formalin
(Sigma, HT501128), dehydrated, paraffin embedded and sec-
tioned (5-µm thickness) prior to staining in hematoxylin and
eosin (H&E). For immunohistochemistry deparaffinized and
rehydrated sections were subjected to microwave-based anti-
gen retrieval in citrate buffer (~ 0.24% trisodium citrate dihy-
drate, ~ 0.038% citric acid, in water). The sections were then
incubated in hydrogen peroxide buffer (10% H2O2 in metha-
nol) to mask any background peroxidase activity followed by
treatment with blocking solution (10% goat serum [Gibco,
16,210–072], 0.30% Triton X-100 in PBS). Sections were
stained with appropriate primary (anti SQSTM1/p62 anti-
body, anti MKI67/Ki67 antibody [Abcam, ab66155], anti
ITGAM/Cd11b antibody [Abcam, ab133357]) and secondary
antibodies (anti rabbit-HRP; Dako, K4003). The signals were
developed with chromogen buffer (Dako, K3468). Tissue sec-
tions were mounted using cover glass and mounting medium
(Neomount; Merck, 1,090,160,100) and imaged using 20X and
40X objectives on a bright-field microscope (Zeiss). The
images were analyzed using Axio Vision software (cell cir-
cumference measurement, Axio Vision SE64 Rel. 4.8) and
ImageJ software (cell counter plugin, NIH, USA). The
obtained data were analyzed (unpaired t test) and plotted
through GraphPad prism 7 software.
Fluorescence imaging
Cells grown on glass coverslips were fixed at −20°C in ice cold
methanol for 7 min, then blocked in 5% goat serum, 0.3% Triton
X-100 in PBS (Sigma, G9023; X100). Cells were incubated with
anti LC3A/B (Cell Signalling Technology, 4108; 1:500 in 1% BSA
[Europa Bioproducts Ltd., EQBAH62-1000], 0.3% Triton X-100
in PBS). Washed cells were incubated with secondary antibody
anti-rabbit-Alexa Fluor 488 (Life Technologies, A11008) and
counterstained with 4ʹ, 6 diamidino-2-phenylindole (DAPI;
ThermoFisher Scientific, 10,116,287) and mounted on slides
with Fluoromount-G from Southern biotech (ThermoFisher
Scientific, 15,586,276). Cells were imaged on a Zeiss Imager
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M2 Apotome microscope with a 63X, 1.4 NA oil-immersion
objective using 365 ± 40 nm excitation and 445 ± 25 nm emis-
sion for DAPI, 470 ± 20 nm excitation and 525 ± 25 nm emission
for LC3. Images were obtained using a Zeiss Axioplan micro-
scope with bright field.
Statistics
Unpaired t test was employed for the data analysis across all
the experiments. The data were analyzed and plotted through
GraphPad prism 7 software.
Microscopy
All the fluorescent imaging was carried out using an Apotome
microscope from Zeiss, fitted with 63X objective. All the immu-
nohistochemistry for bright-field imaging was carried out using
an Axioplan 2 microscope from Zeiss, fitted with 20X, 40X
objectives and a colored Axio Cam HRc camera from Zeiss.
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